04Mar
Global Private Equity Newsletter - Winter 2020 Edition: Deals in the Life Sciences Sector Article 1: Value Drivers and Risks
As the private equity industry matures, and the deal landscape becomes more competitive, private equity sponsors are becoming more prepared and capable of investing in sectors previously considered overly-regulated, requiring advanced chemistry or...
By:
Dechert LLP
Related
Concrete Contractor Fired Worker after He Complained about Assault, Federal Agency Says - BALTIMO...
Read More >
The Guide is intended to provide fresh clarity on the ECB’s approach to assessing proposed M&A tran...
Read More >
The French Competition Authority sanctions a grouping of road hauliers for customer allocation - O...
Read More >
On 13 December 2019 the U.S. Department of Justice's (DOJ) National Security Division (NSD) announce...
Read More >
Antitrust enforcers in the United States and European Union (EU) remained active in 2019, and recent...
Read More >
Most developers are familiar with the notion that under California’s Subdivision Map Act, the vesti...
Read More >